Working… Menu
Trial record 1 of 23 for:    "Vulvitis" | "Steroid Synthesis Inhibitors"
Previous Study | Return to List | Next Study

Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03167957
Recruitment Status : Withdrawn (No longer target indication)
First Posted : May 30, 2017
Last Update Posted : March 8, 2019
Information provided by (Responsible Party):
Matinas BioPharma Nanotechnologies, Inc.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020